Home Newsfeeds Jefferies Maintains Buy on Alphabet, Lowers Price Target to $130

Jefferies Maintains Buy on Alphabet, Lowers Price Target to $130

Jefferies analyst Brent Thill maintains Alphabet (NASDAQ:GOOGL) with a Buy and lowers the price target from $155 to $130.

byBenzinga Newsdesk

July 27, 2022

1 minute read

Jefferies analyst Brent Thill maintains Alphabet (NASDAQ:GOOGL) with a Buy and lowers the price target from $155 to $130.

Immix Biopharma Announces FDA Approval Of IND Application For CAR-T NXC-201, Enabling U.S. Patient Dosing

By Benzinga Newsdesk

November 21, 10:46 AM

NEXICART-2 to expand studies of NXC-201 in relapsed/refractory AL Amyloidosis to U.S. sites based on IND clearance72 patients previously dosed with NXC-201 ex-U.S.First CAR-T program for light-chain (AL)

IMMX

Healthcare Software Firm Waystar Goes IPO Way With Potential $8B Valuation

By Vandana Singh

August 22, 9:24 AM

Waystar Inc, a provider of financial management software for hospitals and medical practices, is reportedly making strides toward an initial public offering (IPO) that could value the company up to $8 billion.

CSD

Workhorse Files Prospectus Supplement In Connection With Special Meeting

By Happy Mohamed

August 21, 4:27 PM

Workhorse Group Inc. (NASDAQ:WKHS) ("Workhorse" or "the Company"), an American technology company focused on pioneering the transition to zero emission commercial vehicles, today filed with the

WKHS

OLB Group Announces Insider Stock Purchases Totaling 114,143 Shares And Corporate Stock Buyback Of 116,172 Shares Under The Company’s Previously Announced Stock Buyback Program To Reduce Its Shares Outstanding Count By 1M Shares

By Benzinga Newsdesk

December 21, 12:37 PM

The OLB Group, Inc., (NASDAQ:OLB), a diversified Fintech eCommerce merchant services provider and Bitcoin mining enterprise, announced today that senior management, including the OLB's Chairman & CEO, Ronny

OLB

Jefferies Maintains Buy on Alphabet, Lowers Price Target to $130

Related Posts

Immix Biopharma Announces FDA Approval Of IND Application For CAR-T NXC-201, Enabling U.S. Patient Dosing

Healthcare Software Firm Waystar Goes IPO Way With Potential $8B Valuation

Workhorse Files Prospectus Supplement In Connection With Special Meeting

OLB Group Announces Insider Stock Purchases Totaling 114,143 Shares And Corporate Stock Buyback Of 116,172 Shares Under The Company’s Previously Announced Stock Buyback Program To Reduce Its Shares Outstanding Count By 1M Shares